pubmed-article:19552746 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C0031809 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C1708335 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C0055538 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C0074554 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C1704675 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C1999216 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C0201734 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C1709518 | lld:lifeskim |
pubmed-article:19552746 | lifeskim:mentions | umls-concept:C2604745 | lld:lifeskim |
pubmed-article:19552746 | pubmed:issue | 5 | lld:pubmed |
pubmed-article:19552746 | pubmed:dateCreated | 2009-6-25 | lld:pubmed |
pubmed-article:19552746 | pubmed:abstractText | Anacetrapib is an orally active, potent inhibitor of cholesteryl ester transfer protein (CETP), which is in development for the treatment of dyslipidaemia. Because of the likely use of anacetrapib with hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, we aimed to evaluate the potential for a pharmacokinetic interaction with simvastatin. | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:language | eng | lld:pubmed |
pubmed-article:19552746 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19552746 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19552746 | pubmed:month | May | lld:pubmed |
pubmed-article:19552746 | pubmed:issn | 1365-2125 | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:WagnerJohn... | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:KrishnaRajesh... | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:JinBoB | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:GargAmitA | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:ChodakewitzJe... | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:KeshavarzSara... | lld:pubmed |
pubmed-article:19552746 | pubmed:author | pubmed-author:BieberdorfFre... | lld:pubmed |
pubmed-article:19552746 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19552746 | pubmed:volume | 67 | lld:pubmed |
pubmed-article:19552746 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19552746 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19552746 | pubmed:pagination | 520-6 | lld:pubmed |
pubmed-article:19552746 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:meshHeading | pubmed-meshheading:19552746... | lld:pubmed |
pubmed-article:19552746 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19552746 | pubmed:articleTitle | Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects. | lld:pubmed |
pubmed-article:19552746 | pubmed:affiliation | Merck & Co., Inc., Whitehouse Station, NJ, USA. rajesh_krishna@merck.com | lld:pubmed |
pubmed-article:19552746 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19552746 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:19552746 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:19552746 | lld:pubmed |